La Jolla researchers discover antibodies that offer broad immunity against SARS viruses, including variants
The findings by Scripps Research scientists open the door for new vaccine approaches and strategies.
Stay updated with breaking news from Integrative Structural. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The findings by Scripps Research scientists open the door for new vaccine approaches and strategies.
Research has opened a new door toward vaccine strategies against SARS viruses.
The study found that nanobodies derived from a llama could be used to develop an inhalable spray to combat COVID-19 and other viral diseases.
Mount Sinai-led researchers have shown that tiny, robust immune particles derived from the blood of a llama could provide strong protection against every COVID-19 variant, including Omicron, and 18 similar viruses including SARS-CoV-2 and SARS-CoV-1, which was responsible for the 2003 SARS outbreak.
WEDNESDAY, June 29, 2022 (HealthDay News) -- Llamas are more than beautiful creatures -- they could also help protect humans from COVID-19 and a large array of similar viruses.